You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 215615

✉ Email this page to a colleague

« Back to Dashboard

NDA 215615 describes METHAZOLAMIDE, which is a drug marketed by Anda Repository, Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Chartwell Rx, and Tagi, and is included in seven NDAs. It is available from ten suppliers. Additional details are available on the METHAZOLAMIDE profile page.

The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the methazolamide profile page.

Summary for 215615

Tradename:	METHAZOLAMIDE
Applicant:	Tagi
Ingredient:	methazolamide
Patents:	0

Medical Subject Heading (MeSH) Categories for 215615

Carbonic Anhydrase Inhibitors
Diuretics

Suppliers and Packaging for NDA: 215615

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
METHAZOLAMIDE	methazolamide	TABLET;ORAL	215615	ANDA	Precision Dose, Inc.	68094-808	68094-808-50	100 TABLET in 1 BOTTLE (68094-808-50)
METHAZOLAMIDE	methazolamide	TABLET;ORAL	215615	ANDA	Precision Dose, Inc.	68094-908	68094-908-50	100 TABLET in 1 BOTTLE (68094-908-50)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	25MG
Approval Date:	Oct 18, 2022	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	50MG
Approval Date:	Oct 18, 2022	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.